EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A New Wnt1 Mutant Rat Model of Osteogenesis Imperfecta and Its Application in AAV9‐Mediated Gene Therapy

Shan Li iD, Xiumin Chen iD, Yixuan Cao iD, Mingchen Han iD, Feifei Guan iD, Xiuzhi Ren iD, Huan Mi iD, Tao Yang iD, Mei Li iD, Xiuli Zhao iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/7351808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 21.05.2026. Verfasst von Shan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rare Diseases, State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical Col…. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Genetic Therapy, Dependovirus, Wnt1 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteogenesis imperfecta (OI) is a genetically and clinically heterogeneous bone disorder, with more than 20 genes contributing to OI development. Previously, we identified WNT1 c.620G > A (p.Arg207His) mutation among Chinese patients with autosomal recessive OI (AR‐OI). This study aims at investigating the causative role of WNT1 deficiency in OI and evaluate whether AAV‐based gene therapy could ameliorate bone abnormalities. We generated and analyzed the Wnt1 R207H/R207H rat model. The AAV9‐Wnt1 virus was delivered via direct intraosseous injection into the femoral marrow cavity of the OI rats to evaluate its therapeutic potential. The homozygous Wnt1 R207H/R207H rat recapitulated key features of AR‐OI, including fractures, reduced bone mass, growth retardation, decreased survival rate, increased osteoclast numbers, diminished osteoblast function and mineralization capacity, compared with heterozygous and wild‐type littermates. In vitro, Wnt1 overexpression in osteoblasts promoted osteoblast activity and bone mineralization. Furthermore, AAV9‐Wnt1 treatment in OI rats resulted in significant recovery of bone density and mechanical strength, stimulation of osteoblast activity, suppression of osteoclast activity, and upregulation of Type I collagen expression. Our study demonstrates that WNT1 c.620G > A (p.Arg207His) is pathogenic, and confirms that AAV‐mediated Wnt1 gene therapy represents a promising strategy for treating OI caused by WNT1 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteogenesis ImperfectaGenetic TherapyDependovirusWnt1 ProteinMutationAnimalsDisease Models, AnimalRatsGenetic VectorsHumansOsteoblastsBone DensityGene Therapy AgentsOsteoclasts

Stichwörter der Autor:innen

Wnt1adeno-associated virus (AAV)animal modelgene therapyosteogenesis imperfecta (OI)

Substanzen

Wnt1 Protein

Autor:innen und Institutionen

  • Center for Rare Diseases, State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, pumch.cn.
  • State Key Laboratory for Complex, Severe, and Rare Diseases, Department of Medical Genetics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical Co…
  • Department of Molecular Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, National Center for Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China, jst-hosp.com.c…
  • National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Sciences, Peking Union Medicine College and Chinese Academy of Medical Sciences, Beijing, China.
  • Key Laboratory in Science and Technology Development Project of Suzhou, Children's Hospital of Soochow University, Suzhou, China.
  • Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China, nhfpc.gov.cn.

ORCID-Profile: Shan Li, Xiumin Chen, Yixuan Cao, Mingchen Han, Feifei Guan, Xiuzhi Ren, Huan Mi, Tao Yang, Mei Li, Xiuli Zhao

Förderung

  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Li, S., Chen, X., Cao, Y., Han, M., Guan, F., Ren, X., Mi, H., Yang, T., Li, M., & Zhao, X. (2026). A New Wnt1 Mutant Rat Model of Osteogenesis Imperfecta and Its Application in AAV9‐Mediated Gene Therapy. Human Mutation, 2026(1). https://doi.org/10.1155/humu/7351808

Vancouver

Li S, Chen X, Cao Y, Han M, Guan F, Ren X, et al. A New Wnt1 Mutant Rat Model of Osteogenesis Imperfecta and Its Application in AAV9‐Mediated Gene Therapy. Human Mutation. 2026;2026(1). doi:10.1155/humu/7351808

BibTeX
@article{Li2026,
  author = {Li, Shan and Chen, Xiumin and Cao, Yixuan and Han, Mingchen and Guan, Feifei and Ren, Xiuzhi and Mi, Huan and Yang, Tao and Li, Mei and Zhao, Xiuli},
  title = {A New Wnt1 Mutant Rat Model of Osteogenesis Imperfecta and Its Application in AAV9‐Mediated Gene Therapy},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/7351808}
}
Kostenlos starten →